EUVIMEDEUVIMED entdecken
Crossref

Can the free/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy?

Rui M Bernardino, Leyi B Yin, Katherine Lajkosz, Jessica G Cockburn, Marian S Wettstein, Dixon Woon, David-Dan Nguyen, Rashid Sayyid, Ricardo Leão, Theodorus van der Kwast, Neil Fleshner

World Journal of Urology · 2024

DOI: 10.1007/s00345-024-05369-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Rui M Bernardino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgical Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada. ruimmbernardino@gm…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Predictive Value of Tests, Prostatectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intraductal carcinoma (IDC) and cribriform pattern (Crib) of prostate cancer are recognised as independent prognosticators of poor outcome, both in prostate biopsies and radical prostatectomy (RP) specimens. OBJECTIVE: This study aimed to determine the predictive value of Free-to-total PSA ratio (FPSAR) in identifying missed IDC/Crib at the time of biopsy as compared to the final surgical specimen. MATERIALS AND METHODS: Patients who underwent RP between January 2015 and December 2022 were included in the study. Predictors of a false negative biopsy were examined using a multivariate logistic regression. Associations between true positive/true negative/false negative biopsies (for IDC/Crib) with FPSAR as primary outcome parameter were determined using Chi-squared test and Kruskal-Wallis test. RESULTS: This study included 639 patients who underwent radical prostatectomy between 2015 and 2022 (Table 1) and had available FPSAR- at the time of biopsy. The median age was 63.0 years (IQR: 58.9-68.0). The median serum PSA before RP was 7.0 ng/ml (IQR: 5.3-9.5). Among the 639 patients, 177 (28%) had Crib, and 97 (15%) had IDC on prostate biopsy, with 54 (9%) patients having both IDC and Crib. Concerning Grade Group distribution at biopsy, there was: GG1 in 62 patients (10%), GG2 in 428 (67%), GG3 in 102 (16%), GG4 in 28 (4%), and GG5 in 19 (3%) patients. On multivariate regression analysis, the following were associated with lower odds of a false-negative IDC/Crib biopsy: Percentage of pattern 4 ≥ 10% at biopsy (odds ratio [OR] 0.17, 95% CI 0.10-0.29; p 0.05). CONCLUSIONS: In conclusion, our study's findings suggest that FPSAR is not a reliable biomarker for identifying IDC/Crib status at the time of biopsy. Further research is needed to identify biomarkers or combinations of biomarkers that can improve the diagnostic accuracy for these aggressive variants of PCa. Our study that involved 639 patients shows that FPSAR is not a good marker for detecting aggressive types of PCa, during a biopsy. More research is needed to find better markers or combinations of markers that can help diagnose these aggressive forms of prostate cancer more accurately.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstate-Specific AntigenPredictive Value of TestsProstatectomyHumansMaleMiddle AgedAgedRetrospective StudiesBiopsyProstateFalse Negative ReactionsCarcinoma, Intraductal, Noninfiltrating

Stichwörter der Autor:innen

False negativesFree to total PSA ratioProstate biopsyProstatic neoplasms

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Division of Urology, Department of Surgical Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada. ruimmbernardino@gmail.com.
  • Computational and Experimental Biology Group, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal. ruimmbernardino@gmail.com.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Department of Statistics, Princess Margaret Cancer Center, Toronto, ON, Canada.
  • Division of Urology, Department of Surgical Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Department of Surgery, The University of Melbourne, Melbourne, VIC, Australia.

Förderung

  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Bernardino, R. M., Yin, L. B., Lajkosz, K., Cockburn, J. G., Wettstein, M. S., Woon, D., Nguyen, D. D., Sayyid, R., Leão, R., van der Kwast, T., & Fleshner, N. (2024). Can the free/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy?. World Journal of Urology. https://doi.org/10.1007/s00345-024-05369-4

Vancouver

Bernardino RM, Yin LB, Lajkosz K, Cockburn JG, Wettstein MS, Woon D, et al. Can the free/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy?. World Journal of Urology. 2024. doi:10.1007/s00345-024-05369-4

BibTeX
@article{Bernardino2024,
  author = {Bernardino, Rui M and Yin, Leyi B and Lajkosz, Katherine and Cockburn, Jessica G and Wettstein, Marian S and Woon, Dixon and Nguyen, David-Dan and Sayyid, Rashid and Leão, Ricardo and van der Kwast, Theodorus and Fleshner, Neil},
  title = {Can the free/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy?},
  journal = {World Journal of Urology},
  year = {2024},
  doi = {10.1007/s00345-024-05369-4}
}
Kostenlos starten →